Printer Friendly

Browse Pharmaceutical industry topic

Licensing agreements subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD. Nov 23, 2021 385
Pfizer strikes global licensing deal for COVID pill. Nov 17, 2021 682
Pfizer signs licensing agreement with UN-backed MPP to allow generic versions of its COVID-19 pill in 95 countries. Nov 17, 2021 236
Pfizer signs licensing agreement with UN-backed MPP to allow generic versions of its COVID-19 pill in 95 countries. Nov 17, 2021 235
Pfizer to allow generic versions of its Covid pill in 95 countries. Reuters News Service Nov 16, 2021 593
Blueprint Medicines signs collaboration and license agreement with Zai Lab. Nov 10, 2021 300
Blueprint Medicines signs collaboration and license agreement with Zai Lab. Nov 10, 2021 301
Karuna Therapeutics, Zai Lab Forge Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China. Nov 10, 2021 531
Integral Molecular signs exclusive worldwide antibody license agreement with AstraZeneca. Nov 4, 2021 167
Integral Molecular signs exclusive worldwide antibody license agreement with AstraZeneca. Nov 4, 2021 166
Dunad Therapeutics signs strategic collaboration and license agreement with Novartis. Nov 3, 2021 172
Dunad Therapeutics signs strategic collaboration and license agreement with Novartis. Nov 3, 2021 173
Merck strikes deal for global access to COVID pill. Oct 28, 2021 596
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit. Oct 28, 2021 858
Merck signs licensing agreement to broaden generic manufacturing of its COVID-19 pill. Oct 27, 2021 230
Merck signs licensing agreement to broaden generic manufacturing of its COVID-19 pill. Oct 27, 2021 231
Merck, MPP enter license agreement for molnupiravir. Oct 27, 2021 159
Xencor Enters Global Collaboration and License Agreement with Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies. Oct 5, 2021 707
Xencor in plamotamab licensing pact with Janssen for $100M upfront, milestones. Oct 4, 2021 408
Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals. Oct 1, 2021 620
Sunovion, Sumitomo Dainippon Pharma and Otsuka Enter Worldwide Development and Commercialization Collaboration. Oct 1, 2021 620
Takeda Pharmaceutical, JCR Pharmaceuticals announce JR-141 license agreement. Sep 30, 2021 213
ViiV Healthcare Inks Exclusive License Agreement with Shionogi to Develop Third-Generation HIV Integrase Inhibitor with Potential for Ultra Long-Acting Dosing Intervals. Sep 28, 2021 396
AM-Pharma, Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan. Sep 9, 2021 834
Sun Pharma and Cassiopea announce completion of HSR Act process and commencement of Winlevi(R) (clascoterone cream 1 percent) agreement. Sep 1, 2021 246
Sun Pharma and Cassiopea announce completion of HSR Act process and commencement of Winlevi(R) (clascoterone cream 1 percent) agreement. Sep 1, 2021 245
Eli Lilly signs multi-year research collaboration and licensing agreement with Lycia Therapeutics. Aug 26, 2021 162
Eli Lilly signs multi-year research collaboration and licensing agreement with Lycia Therapeutics. Aug 26, 2021 163
Eli Lilly, Lycia Therapeutics enter research and licensing agreement. Aug 25, 2021 235
Crescita Therapeutics and Stada Enter 15-Country Exclusive Licensing Agreement for Pliaglis. Aug 18, 2021 397
Licence deal sees pharma firm tap into new market. COREENA FORD Business writer coreena.ford@reachplc.com @Scoopford Aug 13, 2021 450
Astellas, Minovia Therapeutics Forge Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs. Aug 4, 2021 404
Vaccine shortage pushing up SK Bioscience shares. Aug 3, 2021 540
Ligand partner Jazz launches RYLAZE, asparaginase erwinia chrysanthemi. Jul 21, 2021 232
Ligand partner Merck gets FDA approval for VAXNEUVANCE for pneumococcal disease. Jul 19, 2021 201
Aridis, AstraZeneca announce license agreement for suvratoxumab. Jul 19, 2021 162
F-star Therapeutics signs STING compound licensing agreement with AstraZeneca. Jul 8, 2021 155
Spero Therapeutics signs regional licensing agreement with Pfizer. Jul 6, 2021 187
Everest Partner Spero Therapeutics Enters Licensing Agreement with Pfizer Inc. for SPR206 in ex-US and ex-Asia Territories. Jul 6, 2021 447
Spero Therapeutics signs regional licensing agreement with Pfizer. Jul 6, 2021 188
Eureka Therapeutics Inks New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma. Jul 6, 2021 304
VIIV AND HALOZYME ENTER GLOBAL COLLABORATION. Jul 1, 2021 919
ViiV Healthcare, Halozyme Enter Collaboration, License Agreement for Enhanze Drug Delivery Technology to Enable Development of "Ultra Long-Acting" Medicines for HIV. Jun 23, 2021 653
ViiV Healthcare, Halozyme announce Enhanze license agreement. Jun 22, 2021 329
Zai Lab, MacroGenics enters into collaboration to develop, commercialize. Jun 16, 2021 247
NetScientific's ProAxsis to validate and commercialise AstraZeneca's Coronavirus vaccine assay. Jun 8, 2021 213
Proactive news headlines: NetScientific, Arecor Therapeutics, Silence Therapeutics, Scancell Holdings... Jun 8, 2021 1214
Taiwan in talks to join contract manufacturing market for vaccines. Jun 8, 2021 235
AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact. Jun 7, 2021 448
NetScientific shares surge on AstraZeneca Covid-19 test contract. Jun 7, 2021 212
Zai Lab announces first patient treated in China in Phase 2 TRIDENT-1 study. May 28, 2021 227
Xencor Inc licenses its Xtend Fc technology to Bristol-Myers for neutralisation of the SARS-CoV-2 virus. May 26, 2021 244
Xencor Inc licenses its Xtend Fc technology to Bristol-Myers for neutralisation of the SARS-CoV-2 virus. May 26, 2021 243
Xencor, Bristol-Myers in licensing pact for Xtend XmAb technology. May 25, 2021 261
Agenus, Bristol-Myers enter exclusive global license agreement for AGEN1777. May 18, 2021 238
Eli Lilly signs licensing deals with Indian pharmaceutical companies to boost supply of COVID-19 medicines in India. May 10, 2021 180
Eli Lilly signs licensing deals with Indian pharmaceutical companies to boost supply of COVID-19 medicines in India. May 10, 2021 179
VERTEX AND OBSIDIAN TO REGULATE GENE EDITING. May 1, 2021 566
Far East deal for drug helps firm net PS10m in sales. JONATHON MANNING Business writer jonathon.manning@reachplc.com @JONNYAMANNING Apr 30, 2021 616
Melinta Therapeutics, Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives for the Middle East and North Africa Region. Apr 29, 2021 238
Merck expands access of possible Covid-19 treatment with new contracts. Apr 27, 2021 174
Merck Inks Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19. Apr 27, 2021 332
Merck in pact with five Indian generic manufacturers for molnupiravir. Apr 27, 2021 273
C4X Discovery happy in the pre-clinical world as partner list grows. Apr 22, 2021 912
Vertex Pharmaceuticals, Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing. Apr 22, 2021 511
Immunomic Therapeutics Announces License Agreement with Lineage Cell Therapeutics for Cancer Immunotherapy. Apr 21, 2021 861
Kazia Therapeutics licenses global rights to novel, first-in class, clinic-ready oncology drug candidate EVT801. Apr 21, 2021 460
ERS Genomics, Nuvisan ICB Sign CRISPR/Cas9 License Agreement. Apr 20, 2021 194
Genprex targets non-small cell lung cancer and diabetes via gene therapy. Apr 13, 2021 780
C4X Discovery strikes Sanofi licensing deal worth up to [euro]414mln. Apr 13, 2021 237
Proactive headlines: C4X, Alient Metals, AfriTin Mining... Apr 13, 2021 678
C4X Discovery secures EUR414 million licensing deal with Sanofi. Apr 12, 2021 405
C4XD enters licensing agreement with Sanofi for oral IL-17A inhibitor program. Apr 12, 2021 221
Rigel Pharmaceuticals completes Eli Lilly license agreement. Apr 8, 2021 162
Rigel Pharmaceuticals completes Eli Lilly license agreement. Apr 8, 2021 161
Genprex targets non-small cell lung cancer and diabetes via gene therapy. Apr 7, 2021 773
Chinook Therapeutics to create Sairopa company through Van Herk transaction. Apr 5, 2021 386
Genmab announces European approval for Kesimpta (ofatumumab) in relapsing forms of MS. Mar 30, 2021 200
Genmab announces European approval for Kesimpta (ofatumumab) in relapsing forms of MS. Mar 30, 2021 199
Genmab announces European approval for Kesimpta (ofatumumab) in relapsing forms of MS. Mar 30, 2021 198
RedHill Biopharma announces settlement of Movantik patent litigation with MSN. Mar 25, 2021 180
COVID-19: NAFDAC Confirms COVISHIELD Same As Astrazeneca Vaccine. Mar 21, 2021 287
Genevant Sciences Inks Global Collaboration, License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis. Mar 16, 2021 198
NLS Pharmaceutics signs License Agreement with Novartis Pharma AG. Mar 15, 2021 207
NLS Pharmaceutics signs License Agreement with Novartis Pharma AG. Mar 15, 2021 208
Eli Lilly signs research collaboration and license agreement with Biolojic Design. Mar 9, 2021 165
Eli Lilly signs research collaboration and license agreement with Biolojic Design. Mar 9, 2021 164
RIBON THERAPEUTICS SIGNS LICENSE AGREEMENT WITH ONO. Mar 1, 2021 688
BeiGene Forges Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan. Feb 26, 2021 492
Medivir signs license agreement with Ubiquigent. Feb 11, 2021 157
Medivir signs license agreement with Ubiquigent. Feb 11, 2021 153
Antibe Therapeutics Inks China Licensing Deal with Nuance Pharma. Feb 10, 2021 389
Ribon Therapeutics Inks License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries. Feb 2, 2021 500
Evozyne signs a strategic collaboration and license agreement with Takeda Pharmaceutical Company. Jan 26, 2021 226
Evozyne signs a strategic collaboration and license agreement with Takeda Pharmaceutical Company. Jan 26, 2021 222
Loxo Oncology at Lilly signs research collaboration and license agreement with Merus. Jan 20, 2021 230
Loxo Oncology at Lilly signs research collaboration and license agreement with Merus. Jan 20, 2021 226
Medivir signs licensing agreement with IGM Biosciences. Jan 12, 2021 192
Medivir signs licensing agreement with IGM Biosciences. Jan 12, 2021 188
BeiGene Collaborates with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab. Jan 12, 2021 699
ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. Jan 7, 2021 197
ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. Jan 7, 2021 193
Aurobindo Pharma signs deal to produce COVAXX's potential COVID-19 vaccine candidate for India and UNICEF. Dec 24, 2020 194
Compugen Ltd achieves first milestone in license agreement with AstraZeneca. Dec 24, 2020 160
Aurobindo Pharma signs deal to produce COVAXX's potential COVID-19 vaccine candidate for India and UNICEF. Dec 24, 2020 190
Compugen Ltd achieves first milestone in license agreement with AstraZeneca. Dec 24, 2020 156
Amgen signs license agreement with Medicines Development for Global Health. Dec 23, 2020 152
Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. Dec 21, 2020 213
Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. Dec 21, 2020 209
Janux Therapeutics Forges Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology Using T Cell Engager (TRACTr) Technology. Dec 21, 2020 372
Crescendo delivers Humabody molecules and expands collaboration with Takeda. Dec 10, 2020 152
Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. Dec 7, 2020 296
Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. Dec 7, 2020 300
KaliVir Immunotherapeutics partners with Astellas for development and commercialization of VET2-L2 novel oncolytic virus. Dec 7, 2020 233
KaliVir Immunotherapeutics partners with Astellas for development and commercialization of VET2-L2 novel oncolytic virus. Dec 7, 2020 237
Sesen Bio Inks Licensing Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum in the Middle East, North Africa. Dec 4, 2020 499
Novartis in deal to develop potential COVID-19 drugs. Nov 23, 2020 673
Phlilippines eyes Indian-made COVID-19 vaccine. Nov 21, 2020 748
Taiho, Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions. Nov 12, 2020 483
Cogstate expands global licensing deal with Japanese pharma Eisai. Oct 27, 2020 519
Vifor Pharma, Cara Therapeutics Sign US license Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus. Oct 22, 2020 503
IONTAS to license mammalian display technology to Bristol Myers Squibb. Oct 13, 2020 195
IONTAS to license mammalian display technology to Bristol Myers Squibb. Oct 13, 2020 191
Eyenovia to host investor call to discuss licensing agreements. Oct 13, 2020 426
Takeda Pharmaceutical, Arrowhead to co-develop ARO-AAT to treat AATLD. Oct 8, 2020 161
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease. Oct 8, 2020 440
Antares Pharma enters exclusive license agreement with Ferring for Nocdurna. Oct 1, 2020 242
Redx Pharma strikes balance between in-house programmes and partnerships. Sep 12, 2020 648
Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI. Aug 23, 2020 754
Dr. Reddy's Laboratories Launches Avigan in India. Aug 19, 2020 224
Eli Lilly, Innovent announce global expansion of TYVYT licensing agreement. Aug 18, 2020 410
Redx Pharma: the three-year journey from administration to FTSE 100 deal. Aug 15, 2020 1131
RedHill Biopharma and Cosmo Pharma sign licensing and manufacturing agreement. Aug 13, 2020 205
Small Cap Movers: Redx Pharma joins junior biotech success stories. Aug 9, 2020 894
Redx Pharma rockets as it licenses out novel IPF drug to AstraZeneca. Aug 5, 2020 388
Proactive news headlines: RedX Pharma, genedrive, Futura Medical, Open Orphan. Aug 5, 2020 1943
Redx Pharma PLC in a great place to move forward after Astra deal says CEO. Aug 5, 2020 199
Hanmi exports drug candidate material technology to MSD. Aug 4, 2020 269
Sesen Bio Inks Exclusive License Agreement with Qilu Pharmaceutical for the Development and Commercialisation of Vicineum in Greater China. Aug 3, 2020 872
Teva Partner Otsuka Files Japan New Drug Application for Ajovy Injection. Jul 31, 2020 221
Sangamo executes global licensing agreement with Novartis for genomic medicines. Jul 30, 2020 258
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer Therapy. Jul 29, 2020 433
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 327
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 322
Bavarian Nordic signs final licensing agreement with AdaptVac on COVID-19 vaccine. Jul 23, 2020 326
Zymeworks announces new multispecific antibody collaboration with Merck. Jul 8, 2020 154
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 197
BioInvent International extends cancer immunotherapy research collaboration and license agreement term with Pfizer. Jul 2, 2020 193
ABCELLERA SIGNS COLLABORATION AGREEMENT WITH LILLY. Jul 1, 2020 421
Merck, Ridgeback Biotherapeutics close collaboration, licensing deal. Brief article Jul 1, 2020 179
Dare Bioscience announces publication of article reviewing PCT studiesBayer. Jun 24, 2020 312
Dare Bioscience announces publication of article reviewing PCT studies. Jun 24, 2020 261
Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir. Jun 16, 2020 219
Evox Therapeutics signs research collaboration and license agreement with Eli Lilly. Jun 10, 2020 218
Evox Therapeutics signs research collaboration and license agreement with Eli Lilly. Jun 10, 2020 214
AstraZeneca reaches 2bn capacity for coronavirus vaccine doses, receives more funds from Bill Gates' organisation. Jun 6, 2020 334
Jounce Therapeutics regains worldwide rights to JTX-8064 from Bristol-Myers. Jun 4, 2020 165
AstraZeneca reports 'steps towards broad and equitable access' to COVID vaccine. Jun 4, 2020 212
Ligand announces expansion of Icagen license agreement with Roche. May 29, 2020 166
Eden Research and Bayer Animal Health amend agreement. May 28, 2020 308
LAVA THERAPEUTICS COLLABORATES WITH JANSSEN. May 27, 2020 241
AGREEMENT EXPANDS GENPREX ONCOLOGY FRANCHISE. May 27, 2020 579
BLUSTER RISKS LOSING VACCINE; COVID-19 CRISIS: FEARS UK WILL GO TO BACK OF QUEUE FOR JABBritain-first boast could hamper access to treatment. EXCLUSIVE by ALAN SELBY May 24, 2020 333
BLUSTER RISKS LOSING VACCINE; Britain-first boast could hamper access to treatment. EXCLUSIVE BY ALAN SELBY May 24, 2020 333
Hopes for vaccine 'by September' PS84M MORE PUMPED INTO RESEARCH. GAVIN CORDON May 18, 2020 359
Further PS84m ploughed into search for vaccine. GAVIN CORDON Reporter May 18, 2020 563
Shot in the arm for vaccine hunt. May 18, 2020 388
UK steps up vaccine hunt as it pledges extra PS84m; CORONAVIRUS Government also investing millions in manufacturing centres. GAVIN CORDON May 18, 2020 426
PS84m extra for vaccine R&D at top universities. May 18, 2020 171
PS84m extra for vaccine R&D at top universities. May 18, 2020 155
UK to get 30million coronavirus vaccine doses 'by September' -if it works; An Oxford University team has signed a deal with pharma giant AstraZeneca which could mean a large delivery of doses this autumn. But it's 'a big if', Business Secretary Alok Sharma said. By, Dan Bloom May 17, 2020 1110
Pak to soon start manufacturing breakthrough Covid-19 treatment drug Remdesivir under license from US pharmaceutical company Gilead: Zafar Mirza. May 16, 2020 267
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide. May 14, 2020 351
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 254
Cipla partners with Gilead to expand the access of Remdesivir to COVID-19. May 14, 2020 258
Ocular Therapeutix, Regeneron extend cooperation on eye treatment. May 14, 2020 283
Ferozsons subsidiary inks agreement with Gilead for manufacturing 'experimental drug' remdesivir. May 13, 2020 425
Covid-19: Gilead inks deal with Feronzsons for Remdesivir. May 13, 2020 313
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 189
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19. May 13, 2020 185
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 196
AstraZeneca regains rights to Brazikumab from Allergan. May 12, 2020 192
Gilead signs remdesivir licensing deals with Mylan, four other manufacturers. May 12, 2020 177
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19. May 12, 2020 433
Aerpio amends licensing pact with Gossamer Bio on IBD candidate. May 12, 2020 174
Cocrystal reprioritizes development activities to accelerate COVID-19 program. May 11, 2020 621
BioMarin Pharmaceutical, DiNAQOR sign preclinical collaboration and license agreement. May 4, 2020 162
BioMarin Pharmaceutical, DiNAQOR sign preclinical collaboration and license agreement. May 4, 2020 158
ProThera Biologics, Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins. Apr 27, 2020 548
ProThera Biologics signs licensing agreement with Takeda Pharmaceutical. Apr 24, 2020 164
ProThera Biologics signs licensing agreement with Takeda Pharmaceutical. Apr 24, 2020 168
Aytu BioScience announces exclusive ZolpiMist. Apr 8, 2020 156
Hikma wins litigation over heart disease prevention drug. Apr 1, 2020 227
SUDA Pharmaceuticals grants Mitsubishi Tanabe Korea an exclusive licence for ZolpiMist. Mar 24, 2020 326
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences. Mar 5, 2020 407
Hikma in nasal spray licence agreement, full-year profits soar. Feb 28, 2020 396
Hikma in nasal spray licence agreement, full-year profits soar. Feb 28, 2020 394
Karo Pharma reports on termination of agreement with Pfizer. Feb 5, 2020 161
Karo Pharma reports on termination of agreement with Pfizer. Feb 5, 2020 157
Genmab reports worldwide net trade sales of USD2.998bn for DARZALEX in 2019. Jan 23, 2020 291
EnWave Signs Technology License and Joint Development Agreement with GEA Lyophil GmbH to Advance REVa"[cent sign] Technology for Pharmaceutical Applications. Jan 23, 2020 983
Mereo Bio rises after signing licensing agreement with Oncologie Inc. Jan 14, 2020 1998
Ligand signs OmniAb Platform license agreement with Pandion Therapeutics for range of discovery programmes. Jan 14, 2020 181
Allele partners with Astellas for development of iPSC lines. Jan 14, 2020 187
Ligand signs OmniAb Platform license agreement with Pandion Therapeutics for range of discovery programmes. Jan 14, 2020 177
Allele partners with Astellas for development of iPSC lines. Jan 14, 2020 183
85 Biggest Movers From Yesterday. Lisa Levin Jan 14, 2020 2045
41 Stocks Moving In Monday's Mid-Day Session. Lisa Levin Jan 13, 2020 1177
UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance. Jan 13, 2020 795
Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer's Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate. Jan 13, 2020 2662
30 Stocks Moving In Monday's Mid-Day Session. Lisa Levin Jan 6, 2020 705
RedHill Biopharma Regains Rights to its Proprietary Bowel Preparation RHB-106. Jan 2, 2020 1391
Pulmatrix Shares Soar On Licensing Agreement With Johnson & Johnson. Shanthi Rexaline Jan 2, 2020 414
4 Stocks To Watch For December 24, 2019. Lisa Levin Dec 24, 2019 276
Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets. Dec 24, 2019 296
CytoDyn lands commercialization agreement with Vyera Pharmaceuticals to sell leronlimab to treat HIV. Dec 19, 2019 163
Alexion Exercises Option for Two Additional GalXC RNAi Programmes for Complement-Mediated Targets Under Collaboration with Dicerna. Dec 19, 2019 726
HitGen signs drug development license agreement with MTPC. Dec 18, 2019 144
HitGen signs drug development license agreement with MTPC. Dec 18, 2019 140
Ligand awards license to its worldwide OmniAb antibody discovery platform to Sanofi. Dec 3, 2019 216
Ligand awards license to its worldwide OmniAb antibody discovery platform to Sanofi. Dec 3, 2019 212
ImmuPharma's US licensing deal provides a path to commercialisation for flagship lupus drug. Nov 29, 2019 544
ViiV Healthcare plans to develop N6LS. Nov 25, 2019 265
ViiV Healthcare plans to develop N6LS. Nov 25, 2019 261
ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention. Nov 21, 2019 570
Arena Pharmaceuticals honoured by the California Life Sciences Association. Nov 19, 2019 261
Arena Pharmaceuticals honoured by the California Life Sciences Association. Nov 19, 2019 257
The Industry. Nov 14, 2019 2091
Regeneron (NASDAQ:REGN) - Regeneron And Vyriad Announce Strategic Agreement For Discovery And Development Of New Oncolytic Virus Treatments For Cancer -- 6/11/2019. Nov 11, 2019 549
Regeneron Pharmaceuticals signs research collaboration and option licensing agreement with Vyriad. Nov 8, 2019 153
Regeneron Pharmaceuticals signs research collaboration and option licensing agreement with Vyriad. Nov 8, 2019 149
The Industry. Nov 7, 2019 2089
Sun Pharma, AstraZeneca enter into license pact for novel oncology products in China. ANI Nov 6, 2019 310
Karo Phrama reports on termination of project by Pfizer regarding ROR-gamma. Nov 6, 2019 189
Karo Phrama reports on termination of project by Pfizer regarding ROR-gamma. Nov 6, 2019 185
Regeneron and Vyriad to co-develop new virus treatments for cancer. Nov 6, 2019 226
Antengene announces exclusive worldwide license from AstraZeneca for AZD0364. Nov 6, 2019 173
The Industry. Oct 24, 2019 2089
Pfizer Inc UK - Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-Angptl3-LRX -- 7/10/2019. Oct 15, 2019 431
Pfizer Inc. ( NYSE:PFE) - Akcea And Pfizer Inc. Announce Licensing Agreement For Investigative Antisense Therapy Akcea-Angptl3-LRx -- 7/10/2019. Oct 14, 2019 431
Shionogi partners with Hsiri Therapeutics Inc for research into therapeutics for non-tuberculous mycobacterial diseases and TB. Oct 11, 2019 220
Shionogi partners with Hsiri Therapeutics Inc for research into therapeutics for non-tuberculous mycobacterial diseases and TB. Oct 11, 2019 216
The Industry. Oct 10, 2019 2091
Akcea Therapeutics, Pfizer announces licensing agreement for AKCEA-ANGPTL3-L. Oct 7, 2019 229
Goldfinch Bio signs license agreement with Takeda Pharmaceutical Co. Oct 7, 2019 140
Goldfinch Bio signs license agreement with Takeda Pharmaceutical Co. Oct 7, 2019 136
The Industry. Oct 3, 2019 2091
Japan Pharmaceuticals Industry - Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan -- 30/9/2019. Oct 2, 2019 607
Indian Firms Ramp Up R&D: Accelerating on research spend. Harachand, S. Oct 1, 2019 705
SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading. ANI Sep 24, 2019 234
The Industry. Sep 20, 2019 2089
Bayer--Bayer and Informed Data Systems Inc. to develop One Drop digital therapeutics platform for multiple therapeutic areas--17/9/2019. Sep 19, 2019 305
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH Sign Exclusive Licensing Agreement for Volasertib. Sep 19, 2019 408
The Industry. Sep 12, 2019 2093
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion And BridgeBio Announce Japanese License Agreement For Eidos' Transthyretin Amyloidosis (ATTR) Investigational Medicine -- 9/9/2019. Sep 12, 2019 476
Boehringer Ingelheim signs licensing, development and commercialisation contract with Lupin. Sep 6, 2019 206
Boehringer Ingelheim signs licensing, development and commercialisation contract with Lupin. Sep 6, 2019 202
AstraZeneca signs IP agreement with Theragnostics. Sep 5, 2019 103
Biosynthetic Technologies Inks Patent License Agreement with Cayman Chemical for the Global Pharmaceutical and R&D Markets. Sep 5, 2019 624
The Industry. Sep 5, 2019 2088
Astellas Pharma Inc. - RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology -- 2/9/2019. Sep 3, 2019 687
The Industry. Aug 29, 2019 2090
Innovent Biologics signs licensing agreement with Eli Lilly. Aug 22, 2019 108
Innovent Biologics signs licensing agreement with Eli Lilly. Aug 22, 2019 104
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 185
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 181
LEO Pharma sub licenses rights to develop and market brodalumab for treating psoriasis outside of Europe. Aug 14, 2019 222
LEO Pharma sub licenses rights to develop and market brodalumab for treating psoriasis outside of Europe. Aug 14, 2019 218
Japanese Company Obtains License For Hearing Loss Treatment Candidate: Small-Molecule Drug Activates Inner Ear Progenitor Cells. Aug 12, 2019 428
Cocrystal Pharma reports Q2 revenue $592,000 vs. no revenue last year. Financial report Aug 9, 2019 111
Dechra Pharma To Work With Akston Biosciences On Dog Diabetes Drug. Aug 2, 2019 277
ASTELLAS AND FREQUENCY THERAPEUTICS PARTNER. Aug 1, 2019 682
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 168
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 169
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 164
The Industry. Aug 1, 2019 2089
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 185
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 181
Lexicon Shares Fall 47% On Termination Of License Agreement With Sanofi. Jul 29, 2019 189
Verastem Oncology Inks Exclusive License Agreement with Sanofi for the Development and Commercialisation of Copiktra in Russia and CIS, Turkey, the Middle East and Africa. Jul 29, 2019 372
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 239
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 235
Hikma Pharma Inks Africa And Middle East Commercial Deal With Gedeon. Jul 25, 2019 196
Verastem signs commercialization agreement with Sanofi for Copiktra in EMEA. Jul 25, 2019 146
Crescendo Biologics' Second Oncology-targeted Humabody Licensed by Takeda. Jul 24, 2019 338
Astellas Pharma Inc. - Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss -- 17/7/2019. Jul 24, 2019 546
Jounce announces update on strategic collaboration with Celgene. Jul 23, 2019 300
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 148
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 144
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics. Jul 19, 2019 289
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss. Jul 18, 2019 458
China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products. Jul 16, 2019 2190
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 241
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 237
The Industry. Jul 11, 2019 2092
Nicox - Nicox Receives $3 Million Milestone Payment from Eyevance for ZERVIATETM in the U.S. -- 9/7/2019. Jul 11, 2019 239
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jul 9, 2019 1045
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis R and D Pipeline with New First-in-Class Compound from Yuhan Corp. Jul 5, 2019 409
Nicox - Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to [euro]12 million in milestones plus royalties -- 2/7/2019. Jul 5, 2019 383
The Industry. Jul 4, 2019 2094

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |